First Time Loading...

ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 267 JPY -1.18% Market Closed
Updated: May 4, 2024

ASKA Pharmaceutical Holdings Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ASKA Pharmaceutical Holdings Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Cash from Financing Activities
-¥1.8B
CAGR 3-Years
-67%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Financing Activities
-¥302.8B
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Financing Activities
-¥123.5B
CAGR 3-Years
4%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Cash from Financing Activities
-¥60.3B
CAGR 3-Years
17%
CAGR 5-Years
8%
CAGR 10-Years
2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Financing Activities
-¥139.3B
CAGR 3-Years
-12%
CAGR 5-Years
-32%
CAGR 10-Years
-20%
Astellas Pharma Inc
TSE:4503
Cash from Financing Activities
¥478.6B
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ASKA Pharmaceutical Holdings Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-1.8B JPY

Based on the financial report for Mar 31, 2023, ASKA Pharmaceutical Holdings Co Ltd's Cash from Financing Activities amounts to -1.8B JPY.

What is ASKA Pharmaceutical Holdings Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-10%

Over the last year, the Cash from Financing Activities growth was 39%. The average annual Cash from Financing Activities growth rates for ASKA Pharmaceutical Holdings Co Ltd have been -67% over the past three years , -10% over the past five years .